Authors:
Deeks, SG
Barditch-Crovo, P
Collier, A
Smith, A
Miller, M
McGowan, M
Coakley, DF
Citation: Sg. Deeks et al., Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate, J ACQ IMM D, 28(4), 2001, pp. 336-339
Authors:
Alexander, V
Blair, A
Blair, M
Campbell, I
Collier, A
Croll, J
Connacher, A
Craigie, I
Farmer, G
Fisher, M
Gallacher, S
Gray, S
Greene, S
Harrower, A
Jaapp, A
Jung, R
Kelnar, C
Lawrence, J
Leese, G
Leslie, P
Louden, M
MacCuish, A
Matthews, D
MacRury, S
McGregor, M
McKnight, J
McLaren, H
McSporran, B
Morris, A
Murchison, L
Newton, R
Noyes, K
O'Brien, E
Patrick, A
Patterson, C
Pearson, D
Peden, N
Rae, P
Reith, S
Robertson, K
Rooney, D
Ruthven, I
Shepherd, C
Schulga, J
Smail, P
Small, M
Steel, J
Thomson, R
Walker, J
Waugh, N
Citation: V. Alexander et al., Factors influencing glycemic control in young people with type 1 diabetes in Scotland - A population-based study (DIABAUD2), DIABET CARE, 24(2), 2001, pp. 239-244
Authors:
Barditch-Crovo, P
Deeks, SG
Collier, A
Safrin, S
Coakley, DF
Miller, M
Kearney, BP
Coleman, RL
Lamy, PD
Kahn, JO
McGowan, I
Lietman, PS
Citation: P. Barditch-crovo et al., Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults, ANTIM AG CH, 45(10), 2001, pp. 2733-2739
Authors:
Gray-Donald, K
Robinson, E
Collier, A
David, K
Renaud, L
Rodrigues, S
Citation: K. Gray-donald et al., Intervening to reduce weight gain in pregnancy and gestational diabetes mellitus in Cree communities: an evaluation, CAN MED A J, 163(10), 2000, pp. 1247-1251
Authors:
Schooley, RT
Spino, C
Kuritzkes, D
Walker, BD
Valentine, FT
Hirsch, MS
Cooney, E
Friedland, G
Kundu, S
Merigan, TC
McElrath, MJ
Collier, A
Plaeger, S
Mitsuyasu, R
Kahn, J
Haslett, P
Uherova, P
deGruttola, V
Chiu, S
Zhang, B
Jones, G
Bell, D
Ketter, N
Twadell, T
Chernoff, D
Rosandich, M
Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364
Authors:
Akridge, R
Hladik, F
Markee, J
Alef, C
Kelley, H
Collier, A
McElrath, MJ
Citation: R. Akridge et al., Cellular immunity and target cell susceptibility in persons with repeated HIV-1 exposure, IMMUNOL LET, 66(1-3), 1999, pp. 15-19
Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Authors:
Goh, WC
Markee, J
Akridge, RE
Meldorf, M
Musey, L
Karchmer, T
Krone, M
Collier, A
Corey, L
Emerman, M
McElrath, MJ
Citation: Wc. Goh et al., Protection against human immunodeficiency virus type 1 infection in persons with repeated exposure: Evidence for T cell immunity in the absence of inherited CCR5 coreceptor defects, J INFEC DIS, 179(3), 1999, pp. 548-557